Cite
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.
MLA
Weber, Alexander N. R., et al. “Oncogenic MYD88 Mutations in Lymphoma: Novel Insights and Therapeutic Possibilities.” Cancer Immunology, Immunotherapy, vol. 67, no. 11, Nov. 2018, pp. 1797–807. EBSCOhost, https://doi.org/10.1007/s00262-018-2242-9.
APA
Weber, A. N. R., Cardona Gloria, Y., Çınar, Ö., Reinhardt, H. C., Pezzutto, A., & Wolz, O.-O. (2018). Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities. Cancer Immunology, Immunotherapy, 67(11), 1797–1807. https://doi.org/10.1007/s00262-018-2242-9
Chicago
Weber, Alexander N. R., Yamel Cardona Gloria, Özcan Çınar, H. Christian Reinhardt, Antonio Pezzutto, and Olaf-Oliver Wolz. 2018. “Oncogenic MYD88 Mutations in Lymphoma: Novel Insights and Therapeutic Possibilities.” Cancer Immunology, Immunotherapy 67 (11): 1797–1807. doi:10.1007/s00262-018-2242-9.